Search
Abt-925 anhydrous free base
go.drugbank.com/drugs/DB33803InvestigationalCategories: Heterocyclic Compounds, 1-RingE-7016
go.drugbank.com/drugs/DB33808InvestigationalCategories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingSynonyms: E 7016, E-7016PF-03049423 FREE BASE
go.drugbank.com/drugs/DB33809InvestigationalCategories: Heterocyclic Compounds, 1-Ring, Phosphodiesterase 5 InhibitorsD-Asparagine
go.drugbank.com/drugs/DB03943ExperimentalA non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase.
Synonyms: D-AsparagineLeukocyte Platelet Rich Fibrin
go.drugbank.com/drugs/DB34000ExperimentalLeukocyte Platelet Rich Fibrin is a biologic drug. … Leukocyte Platelet Rich Fibrin is under investigation in clinical trial NCT07836725 (Radiographic Changes in the Maxillary Sinus Following Closed Sinus Augmentation With Leukocyte Platelet Rich Fibrin)
Synonyms: L-prfAnti-CD19/CD22 Dual-Target Cord Blood CAR-T Cells
go.drugbank.com/drugs/DB34005ExperimentalAnti-CD19/CD22 Dual-Target Cord Blood CAR-T Cells is a biologic drug. … Anti-CD19/CD22 Dual-Target Cord Blood CAR-T Cells is under investigation in clinical trial NCT07838714 (Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed
Synonyms: Anti-CD19/CD22 Dual-Target Cord Blood CAR-T CellsCITY-RBP4
go.drugbank.com/drugs/DB34001ExperimentalCITY-RBP4 is a biologic drug. CITY-RBP4 is under investigation in clinical trial NCT07836452 (A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants).
Hemin
go.drugbank.com/drugs/DB03404ApprovedInvestigationalHemin (trade name Panhematin) is an iron-containing porphyrin. More specifically, it is protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds with 4 or More RingsProducts: NORMOSANG® 25MG/ML, PANHEMATIN® POLVO ESTERIL LIOFILIZADO PARA INYECCIÓN 350 MG/ VIAL